AAA_Steve Palmer Alpha North AGN - pending

Source: Streetwise Reports (1/24/22)

‘Strong Data’ Expected From Todos Medical Data Lock
Source: Vision and Value (01/24/2022)

Todos Medical is set to take on the dominant players in oral antivirals for mild to moderate COVID-19, Pfizer Inc. and Merck & Co. Inc., with "strong data" expected to be released soon for its drug Tollovir.

First NSCLC Patient Dosed With Trial Therapeutic
Source: Streetwise Reports (01/22/2022)

Two recent Vaccitech events, the MAGE trial initial dosing and the acquisition of Avidea's SNAPvax technology, bode well for its ChAdOx1-MVA platform, noted an H.C. Wainwright & Co. report.

Fund Triples Holding of Drug Repurposing Firm
Source: Streetwise Reports (01/20/2022)

Several events slated to happen this year could boost Algernon Pharmaceuticals' share price, noted an AlphaNorth Partners Fund performance report.

Shares of Zogenix Inc. rose by 66% after the company reported it entered into an agreement to be acquired by UCB. S.A. of Belgium for $26.00 per share in cash. The offer includes the potential for an additional $2.00 per share if a specific drug approval milestone is met.